Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Shares Issued (2018 - 2025)

Historic Shares Issued for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to $1000.0.

  • Bicycle Therapeutics' Shares Issued rose 10010.21% to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4000.0, marking a year-over-year decrease of 9999.93%. This contributed to the annual value of $544.1 million for FY2024, which is 11822.25% up from last year.
  • Latest data reveals that Bicycle Therapeutics reported Shares Issued of $1000.0 as of Q3 2025, which was up 10010.21% from $1000.0 recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' Shares Issued ranged from a high of $543.2 million in Q2 2024 and a low of -$979000.0 during Q3 2024
  • Its 5-year average for Shares Issued is $60.6 million, with a median of $2.3 million in 2023.
  • As far as peak fluctuations go, Bicycle Therapeutics' Shares Issued soared by 293865000.0% in 2021, and later tumbled by 10041.75% in 2024.
  • Over the past 5 years, Bicycle Therapeutics' Shares Issued (Quarter) stood at $188.4 million in 2021, then tumbled by 97.4% to $4.9 million in 2022, then crashed by 99.8% to $10000.0 in 2023, then tumbled by 9890.0% to -$979000.0 in 2024, then surged by 100.1% to $1000.0 in 2025.
  • Its Shares Issued was $1000.0 in Q3 2025, compared to $1000.0 in Q2 2025 and $2000.0 in Q1 2025.